Back

Are cancer survivors at greater risk of coronary artery disease?

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Epidemiology and risk factors in cardiovascular disease Prevention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Cheng Hwee Soh

Baker Heart and Diabetes Institute, Melbourne (Australia)

7 More presentations in this session

Presentation thumbnail
Ethnic variations in post ST elevation myocardial infarction inflammatory kinetics
Doctor M. Sadler (London, GB)
Abstract Slides Video
Presentation thumbnail
Standard modifiable risk factors (SMuRF) paradox for the prognosis in the patients with acute myocardial infarction
Doctor A. Takasaki (Tsu, JP)
Abstract Slides Video
Presentation thumbnail
ChineseCVD: a web-based Chinese-specifi c cardiovascular risk calculator incorporating long COVID, COVID-19vaccination, SGLT2i and PCSK9i treatment effects
Professor G. Tse (Hong Kong, CN)
Abstract Slides Video
Presentation thumbnail
Which is better for predicting and discriminating cardiovascular events: a traditional risk score, a calcium score or a genetic risk score?
Doctor F. Sousa (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Sex differences in clinical characteristics, phenotypes, management, and long-term outcomes of myocardial injury: an international cohort study
Mr C. Spagnuolo (Basel, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Epidemiology and risk factors in cardiovascular disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
ASCVD risk scores versus a novel cancer-specific Machine Learning-based calculator among patients with breast, colorectal, lung or prostate cancer
thumbnail
Congress Presentation
Increased cardiovascular risk and cardiac dysfunction in cancer survivors from UK Biobank
thumbnail
Congress Presentation
Prognostic value of asymptomatic coronary artery disease and coronary artery calcium score for the risk of cancer therapy-related cardiac dysfunction (ANTEC study)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources